Last reviewed · How we verify
NCT04604145
Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR
NA trial testing SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen in SARS-CoV Infection in 60 participants. Completed in 18 August 2021.
18 August 2021
Quick facts
| Lead sponsor | David Grant U.S. Air Force Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 60 |
| Start date | 3 February 2021 |
| Primary completion | 18 August 2021 |
| Estimated completion | 18 August 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen
Conditions studied
- SARS-CoV Infection — all drugs for SARS-CoV Infection →
- Polymerase Chain Reaction — all drugs for Polymerase Chain Reaction →
- Laboratory Testing — all drugs for Laboratory Testing →
Sponsor
David Grant U.S. Air Force Medical Center
Who can join
18 and older, any sex, with SARS-CoV Infection or Polymerase Chain Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a study that will attempt to validate the process for detecting SARS-CoV-2 (COVID19) on a non-FDA-approved technology using self-collected saliva as the specimen. Investigators will compare self-collected saliva samples and healthcare-worker collected nasopharyngeal samples (Nasal swabs) to see if the self-collected saliva samples are similar in terms of diagnostic accuracy. Investigators will be performing this testing at the site where patients regularly go for COVID19 testing. There will be minimal risk of harm as consenting patients will only have to provide a small amount of saliva into a tube.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04604145
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV Infection
Currently open trials in the same condition.
- NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
- NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
- NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
- NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
- NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting
Other David Grant U.S. Air Force Medical Center trials
Trials by the same sponsor.
- NCT06955923 — Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty · Phase 2 · completed
- NCT06911359 — The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis · Phase 2 · recruiting
- NCT05071196 — Facilitated Vegan Diet on Cardiometabolic Endpoints and Trimethylamine N-oxide · NA · unknown
- NCT04646642 — Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers · completed
- NCT04451070 — Impact of Curricular Transformation on Family Medicine Resident Burnout · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04604145 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by David Grant U.S. Air Force Medical Center
- Last refreshed: 30 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04604145.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing